Other Vascular Disorders

Published on 05/03/2015 by admin

Filed under Dermatology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 13019 times

87

Other Vascular Disorders

This chapter covers a range of vascular disorders from livedo reticularis to common vascular ectasias such as venous lakes and telangiectasias. Additional disorders characterized by proliferation of blood vessels are covered in Chapters 85 (infantile hemangiomas and vascular malformations) and 94 (vascular neoplasms).

Livedo Reticularis

Blue-violet netlike pattern that reflects an increase in deoxygenated blood within the venous plexus of the skin (Fig. 87.1); this increase can be due to a number of causes, including vasospasm of arterioles supplying the skin and sluggish flow due to hypercoagulability or luminal pathology.

A common physiologic vasospastic response to cold that resolves with rewarming, as well as a sign of a number of systemic diseases, from severe atherosclerosis to systemic lupus erythematosus (Table 87.1; Fig. 87.2).

Most commonly observed on the legs but may be more widespread, especially in the setting of systemic diseases.

DDx: early phase of erythema ab igne; viral exanthems (e.g. erythema infectiosum), retiform purpura and necrosis due to more complete disruption of blood flow (Fig. 87.3; see Chapter 18); underlying etiologies are outlined in Table 87.1.

Rx: can improve with treatment of an underlying systemic disorder; no treatment currently available for the idiopathic form.

Telangiectasias

Hereditary Hemorrhagic Telangiectasia (Osler–Weber–Rendu Disease)

Autosomal dominant disorder due to mutations in several genes, particularly the two that encode endoglin and ALK-1, both of which are TGF-β receptors expressed in the vascular endothelium.

The vascular lesions are actually arteriovenous malformations and are found in the skin, mucous membranes, GI tract, CNS, and other visceral organs (e.g. lung, liver); the disorder most often initially presents as recurrent epistaxis due to involvement of the nasal mucosa, with hemorrhage at other sites usually occurring later in life.

The oral mucosal lesions (tongue, lips) usually appear during adolescence and predate the cutaneous ‘telangiectasias’ (face, hands); there is an increase in the overall number of lesions with time (Fig. 87.9).

Clinical criteria: (1) spontaneous recurrent epistaxis, (2) characteristic mucocutaneous telangiectasias/AVMs, (3) visceral telangiectasias/AVMs, and (4) HHT in a first-degree relative; definite diagnosis if ≥3 criteria and possible/suspected diagnosis if 1 or 2 criteria (especially in children and young adults).

Evaluation is outlined in Table 87.5.

Rx: laser therapy, diathermy, transcatheter embolotherapy (e.g. for lung AVMs so as to avoid right-to-left shunting and risk of paradoxical embolization), surgical intervention.